Aurélie Najm1, Benoît le Goff2, Guillaume Venet3, Thomas Garraud2, Jérôme Amiaud4, Noura Biha4, Céline Charrier4, Sophie Touchais5, Vincent Crenn5, Frédéric Blanchard4, Veit Krenn6. 1. Rheumatology Department, Nantes University Hospital, 44093 Nantes, France; Inserm UMR 1238 Laboratory, Phy-Os, 44093 Nantes, France. Electronic address: aurelie.najm@gmail.com. 2. Rheumatology Department, Nantes University Hospital, 44093 Nantes, France; Inserm UMR 1238 Laboratory, Phy-Os, 44093 Nantes, France. 3. Orthopaedic surgery Department, La Roche sur Yon Hospital, 85925 La Roche sur Yon cedex 9, France. 4. Inserm UMR 1238 Laboratory, Phy-Os, 44093 Nantes, France. 5. Orthopaedic surgery Department, Nantes University Hospital, 44093 Nantes, France. 6. MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, 54296 Trier, Germany.
Abstract
OBJECTIVES: Krenn synovitis Score has been developed by Krenn et al. in order to assess synovitis severity and is used in synovial research. Cell signature of synovial tissue can be studied using immunohistochemistry and is of interest as a biomarker for both prognosis and prediction of response to treatment. However, no synovitis score including immunohistochemistry exists yet. In order to answer this unmet need, we propose a new Immunologic Synovitis score (IMSYC) adding 5 components to the Krenn score: CD68, CD3, CD20, CD31 and Ki67 immunostaining. In this study, we aimed to validate this new IMSYC by studying its diagnostic performances in a well-defined collection of synovial samples. METHODS: Synovial samples from patients were obtained during surgical procedures. CD68, CD3, CD20, CD31 and KI67 immunohistochemistry were performed. RESULTS: In total, 77 patients were included. In total, 45 were females, mean age was 63.1 years. Forty had inflammatory arthritis, mainly rheumatoid arthritis (31/40). Non inflammatory arthritis group included 35 patients with mainly osteoarthritis. Mean Krenn score and IMSYC were significantly higher in the inflammatory group (P<0.001). ROC analysis of diagnostic performances determined the score of 13.5 out of 24 as the cut-off that gave the best ratio for discrimination between inflammatory and non-inflammatory arthritis with a sensitivity of 71.8% and specificity of 98%. CONCLUSION: We propose a new synovitis score including immunohistochemistry. This score has a better sensitivity and specificity than the Krenn score and represents a more functional synovitis evaluation. IMSYC could be further used in better categorizing synovial tissue phenotype and give a basis for tissue driven therapy.
OBJECTIVES: Krenn synovitis Score has been developed by Krenn et al. in order to assess synovitis severity and is used in synovial research. Cell signature of synovial tissue can be studied using immunohistochemistry and is of interest as a biomarker for both prognosis and prediction of response to treatment. However, no synovitis score including immunohistochemistry exists yet. In order to answer this unmet need, we propose a new Immunologic Synovitis score (IMSYC) adding 5 components to the Krenn score: CD68, CD3, CD20, CD31 and Ki67 immunostaining. In this study, we aimed to validate this new IMSYC by studying its diagnostic performances in a well-defined collection of synovial samples. METHODS: Synovial samples from patients were obtained during surgical procedures. CD68, CD3, CD20, CD31 and KI67 immunohistochemistry were performed. RESULTS: In total, 77 patients were included. In total, 45 were females, mean age was 63.1 years. Forty had inflammatory arthritis, mainly rheumatoid arthritis (31/40). Non inflammatory arthritis group included 35 patients with mainly osteoarthritis. Mean Krenn score and IMSYC were significantly higher in the inflammatory group (P<0.001). ROC analysis of diagnostic performances determined the score of 13.5 out of 24 as the cut-off that gave the best ratio for discrimination between inflammatory and non-inflammatory arthritis with a sensitivity of 71.8% and specificity of 98%. CONCLUSION: We propose a new synovitis score including immunohistochemistry. This score has a better sensitivity and specificity than the Krenn score and represents a more functional synovitis evaluation. IMSYC could be further used in better categorizing synovial tissue phenotype and give a basis for tissue driven therapy.
Authors: Søren Andreas Just; Christian Nielsen; Jens Christian Werlinrud; Pia Veldt Larsen; Camilla Schufri Klinkby; Henrik Daa Schrøder; Fran Humby; Trine Torfing; Hanne Lindegaard Journal: RMD Open Date: 2019-07-08
Authors: Christopher Schmidt; Rudolf Reich; Bernd Koos; Taila Ertel; Marcus Oliver Ahlers; Martin Arbogast; Ima Feurer; Mario Habermann-Krebs; Tim Hilgenfeld; Christian Hirsch; Boris Hügle; Thekla von Kalle; Johannes Kleinheinz; Andreas Kolk; Peter Ottl; Christoph Pautke; Merle Riechmann; Andreas Schön; Linda Skroch; Marcus Teschke; Wolfgang Wuest; Andreas Neff Journal: J Clin Med Date: 2022-03-22 Impact factor: 4.241
Authors: Juliana Jamal; Margaret M Roebuck; Amanda Wood; Alasdair Santini; George Bou-Gharios; Simon P Frostick; Pooi-Fong Wong Journal: Data Brief Date: 2022-03-21
Authors: Haider Mussawy; Jozef Zustin; Andreas M Luebke; André Strahl; Veit Krenn; Wolfgang Rüther; Tim Rolvien Journal: Arch Orthop Trauma Surg Date: 2021-04-10 Impact factor: 2.928